Viral Oncoprotein Inhibition of Quiescence
病毒癌蛋白对静止的抑制
基本信息
- 批准号:7647592
- 负责人:
- 金额:$ 45.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:Cell CycleDevelopmentGrowth FactorKnowledgeLinkMalignant NeoplasmsMolecularNeoplastic Cell TransformationNormal CellOncogene ProteinsPapovaviridaePathway interactionsPerformanceProcessProliferatingPropertyProtein Phosphatase 2A Regulatory Subunit PR53Signal Transduction PathwayTherapeuticViralWorkcancer celldeprivationtransforming virustumor
项目摘要
Acute infection by the small DNA tumor virus, SV40, can drive quiescent mammalian cells into the cell cycle.
At least part of this work is performed by SV40 LT, one of the two viral oncoproteins. The rest is performed
by the other oncoprotein, SV40 ST. The role of ST in this process depends upon its ability to interfere with
the function of the protein phosphatase, PP2A, the product of a known human.tumor suppressing gene.
Unexpectedly, at least part of the mechanism underlying SV40 ST perturbation of quiescence control is
directed at events that occur in G2 (or G2/M). The process targeted by ST during G2 is PP2A- dependent
and must be intact for cells to quiesce following mitogen deprivation initiated during the next G1 phase. Also
involved is the p130/E2F4/DREAM complex, the integrity of which is PP2A dependent, This complex has
been shown to operate in the maintenance of quiescence. Whether G2-centered PP2A function and/or
PP2A function operating at another time(s) during the cell cycle communicates with this complex to license
quiescence is unclear. The thrust of the proposed research is aimed at understanding 1) how, in molecular
terms, the G2 quiescence control process operates, 2) whether its perturbation contributes to SV40 STdependent
neoplastic transformation and tumorigenesis and 3), if this is the case, how its perturbation elicits
these effects.
小DNA肿瘤病毒SV40的急性感染可以促使静止的哺乳动物细胞进入细胞周期。
这项工作的至少一部分是由两种病毒癌蛋白之一的 SV40 LT 完成的。其余执行
由另一种癌蛋白 SV40 ST 产生。 ST 在此过程中的作用取决于其干扰的能力
蛋白磷酸酶 PP2A 的功能,PP2A 是已知的人类肿瘤抑制基因的产物。
出乎意料的是,静息控制的 SV40 ST 扰动的至少部分机制是
针对 G2(或 G2/M)中发生的事件。 ST 在 G2 期间的目标过程依赖于 PP2A
并且必须保持完整,以便细胞在下一个 G1 期启动有丝分裂原剥夺后静止。还
涉及的是 p130/E2F4/DREAM 复合体,其完整性依赖于 PP2A,该复合体具有
已被证明可以在维持静止状态中发挥作用。是否以 G2 为中心的 PP2A 功能和/或
PP2A 功能在细胞周期的另一个时间运行,与该复合体通信以获取许可
静止状态不明。拟议研究的主旨旨在了解 1)如何在分子中
术语,G2 静止控制过程运行,2) 其扰动是否有助于 SV40 STdependent
肿瘤转化和肿瘤发生,3)如果是这种情况,它的扰动如何引起
这些影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Morse LIVINGSTON其他文献
DAVID Morse LIVINGSTON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Morse LIVINGSTON', 18)}}的其他基金
Deciphering the mechanism underlying BRCA1 breast cancer development
破译 BRCA1 乳腺癌发生的机制
- 批准号:
10218120 - 财政年份:2019
- 资助金额:
$ 45.18万 - 项目类别:
Deciphering the mechanism underlying BRCA1 breast cancer development
破译 BRCA1 乳腺癌发生的机制
- 批准号:
9814452 - 财政年份:2019
- 资助金额:
$ 45.18万 - 项目类别:
BRCA 1 and 2 and Breast Cancer Development
BRCA 1 和 2 与乳腺癌的发展
- 批准号:
8215974 - 财政年份:2011
- 资助金额:
$ 45.18万 - 项目类别:
相似国自然基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
- 批准号:32070202
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
- 批准号:
- 批准年份:2020
- 资助金额:40 万元
- 项目类别:
相似海外基金
The role of Transforming Growth Factor Beta signaling in vertebrate ocular development
转化生长因子β信号在脊椎动物眼部发育中的作用
- 批准号:
558493-2021 - 财政年份:2022
- 资助金额:
$ 45.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
The role of Transforming Growth Factor Beta signaling in vertebrate ocular development
转化生长因子β信号在脊椎动物眼部发育中的作用
- 批准号:
558493-2021 - 财政年份:2021
- 资助金额:
$ 45.18万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Development of Predictive Markers for Sensitivity to Fibroblast Growth Factor Receptor Inhibitors Using Colorectal Cancer Stem Cells
使用结直肠癌干细胞开发成纤维细胞生长因子受体抑制剂敏感性的预测标记
- 批准号:
21K20818 - 财政年份:2021
- 资助金额:
$ 45.18万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
An Investigation to Identify Risk Factors for the Development of Acneiform Eruptions in Patients on Epidermal Growth Factor Receptor Inhibitors
一项旨在确定使用表皮生长因子受体抑制剂的患者发生痤疮样皮疹的危险因素的调查
- 批准号:
466972 - 财政年份:2021
- 资助金额:
$ 45.18万 - 项目类别:
Studentship Programs
The role of phospholipase C-gamma in the fibroblast growth factor dependent lacrimal gland development
磷脂酶C-γ在成纤维细胞生长因子依赖性泪腺发育中的作用
- 批准号:
517003-2018 - 财政年份:2019
- 资助金额:
$ 45.18万 - 项目类别:
Postdoctoral Fellowships
Development of a Novel Therapeutic Agent for Hormone-Resistant Breast Cancer by Targeting the Growth Factor Receptor Pathway
通过靶向生长因子受体途径开发激素抵抗乳腺癌的新型治疗剂
- 批准号:
19K18065 - 财政年份:2019
- 资助金额:
$ 45.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mast cells can produce transforming growth factor b1 and promote tissue fibrosis during the development of Sjogren's syndrome-related sialadenitis
在干燥综合征相关唾液腺炎的发展过程中,肥大细胞可以产生转化生长因子 b1 并促进组织纤维化
- 批准号:
19K08898 - 财政年份:2019
- 资助金额:
$ 45.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Growth Factor Signaling and Craniofacial Development
生长因子信号传导和颅面发育
- 批准号:
10461030 - 财政年份:2018
- 资助金额:
$ 45.18万 - 项目类别:
Delineating the role of insulin-like growth factor binding protein 7 in mammary gland development
描述胰岛素样生长因子结合蛋白 7 在乳腺发育中的作用
- 批准号:
RGPIN-2014-03689 - 财政年份:2018
- 资助金额:
$ 45.18万 - 项目类别:
Discovery Grants Program - Individual
Development of small molecule inhibitors blocking unconventional secretion of Fibroblast Growth Factor 2, a potent tumour cell survival factor - Knowledge Transfer Project
开发小分子抑制剂,阻断成纤维细胞生长因子 2 的非常规分泌,成纤维细胞生长因子 2 是一种有效的肿瘤细胞存活因子 - 知识转移项目
- 批准号:
389866291 - 财政年份:2018
- 资助金额:
$ 45.18万 - 项目类别:
Research Grants (Transfer Project)














{{item.name}}会员




